Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
EBITDA Archives - Page 2 of 3 - The Pharma Times | Pharma & Health Care News Portal

EBITDA

Piramal’s Pharma business grows over 10 % to 4,786 Crore in FY19

 The margins have improved from 10% in FY2011 to 23% in FY2019 Growth is attributed to revenues derived from niche…

5 years ago

ICRA: Hospital sector on recovery path after more than two years of underperformance

New Delhi, July 10, 2019: The Hospital sector is seeing better days ahead after more than two years of subdued…

5 years ago

DIL Limited on the growth path, delivers another year of strong growth

Mumbai, May 28, 2019: DIL Ltd. (BSE: 506414) today announced the results for the fourth quarter of the current financial…

5 years ago

LANXESS: Stable business development in the first quarter of 2019 despite economic downturn

 Sales on previous-year level at  EUR 1.822 billion EBITDA pre exceptionals up 1.9 percent to  EUR 275 million EBITDA margin…

5 years ago

Jubilant Life Sciences – Q4 & 12M’FY19 Results

  JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775…

5 years ago

Jubilant Life Sciences – Q3 & 9M’FY19 Results

New  Delhi, February 02, 2019:  JUBILANT REPORTSRECORD PERFORMANCE IN Q3’FY19 Revenue up 15% YoY to Rs. 2,377 Crore; EBITDA up…

5 years ago

Following a solid third quarter, LANXESS confirms its earnings forecast for 2018

Sales increased by 4.4 percent to EUR 1.79 billion in the third quarter EBITDA pre exceptionals 1.5 percent higher at…

5 years ago

Acquisition of Avenue Therapeutics to be Credit Neutral for Cipla

New Delhi, December 18, 2018: India Ratings and Research (Ind-Ra) believes that Cipla Limited’s (IND AAA/Stable) proposed acquisition of the…

5 years ago

ICRA: Hospital sector continues to be under weather in Q2 FY2019

Operating margin drops from 15.0% in Q2 FY2018 to 13.3% In Q2 FY2019 Structurally, in the long term, underlying fundamentals…

5 years ago

Apollo Hospitals announces Q2 & H1FY19 results

New Delhi, November 24, 2018: Launched the first-ever AI-powered Cardiovascular Disease Risk Score API (Application Program Interface), designed specifically to…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420